Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Risk factors

Topic: Amyloid, tau and blood-test diagnosis

Abstract Background Elevated levels of amyloid are associated with worse performance on cognitive mapping (CM), a spatial navigation task reliant on the hippocampus. Prior animal work found that exercise is associated with better learning in CM tasks. Hence, the first goal of the study was to examine whether physical activity moderates the relationship between amyloid deposition and CM. In addition, spatial navigation ability predicts Alzheimer disease (AD) clinical progression but there is a need to examine whether it also predicts subsequent levels of amyloid and tau. Hence, the second goal was to examine whether CM predicts later levels of PET‐Tau and longitudinal trajectories of PET‐Amyloid. Method Cognitively normal individuals (n = 65; age range 50‐84 years) were administered a CM task in a virtual environment and a self‐report measure of physical activity. For cross‐sectional analyses, amyloid deposition was estimated via cerebrospinal fluid levels of Aβ42. One assessment of PET‐Tau (n = 49) and repeated assessments of PET‐Amyloid (n = 59) were obtained following the CM session. Result Concurrent amyloid deposition was associated with reduced learning (p = 0.002) and retention of the environment (p = 0.002) while greater physical activity was associated with better learning (p = 0.004). There was no moderation by physical activity (all p’s > 0.156). CM performance was not associated with longitudinal trajectories of PET‐Amyloid (all p’s > 0.330) or the subsequent levels of PET‐Tau (all p’s > 0.572). Conclusion These results suggest that both current physical activity and levels of amyloid can be important predictors of spatial navigation skills. However, CM might be a limited predictor of AD biomarker accumulation. Future studies should use a larger sample size and greater number of assessments to examine these questions.

Key findings

Why it matters

In this small study of cognitively normal adults, higher amyloid levels were linked to worse performance on a spatial navigation task, and greater physical activity was linked to better learning, but physical activity did not change the relationship between amyloid and learning. Spatial navigation performance did not predict later tau or amyloid levels, so it is unclear whether this task can be used to track Alzheimer's disease progression.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 43 of 100.43 of 100 points earned57 not earned

Published in a leading specialty journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Alzheimer's & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 1 / 4 65 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 5 year(s) since 2023
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Denise M Head: h-index 44 (OpenAlex, whole career)
Institution's track record 2 / 3 Washington University in St. Louis: institution h-index 1,962 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Stojanovic, M., Allison, S. L., Schindler, S. E., & Head, D. M. (2023). Spatial navigation, physical activity, and Alzheimer disease biomarkers. Alzheimer's & Dementia. https://doi.org/10.1002/alz.077004

Vancouver

Stojanovic M, Allison SL, Schindler SE, Head DM. Spatial navigation, physical activity, and Alzheimer disease biomarkers. Alzheimer's & Dementia. 2023. doi:10.1002/alz.077004.

BibTeX

@article{stojanovic2023-061e8f8a,
  author  = {Stojanovic, Marta and Allison, Samantha L. and Schindler, Suzanne E. and Head, Denise M},
  title   = {{Spatial navigation, physical activity, and Alzheimer disease biomarkers}},
  journal = {Alzheimer's \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.077004},
  url     = {https://doi.org/10.1002/alz.077004}
}

Related studies in Risk factors

Similar studies

More on Risk factors

See all studies in Risk factors →